Loading...
NPI 1467066860 · Houston, TX · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Pcltx LLC is a clinical medical laboratory provider located in Houston, Texas. This profile covers 26 Medicare and 29 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Pcltx LLC |
| Address | 8300 Cypress Creek Pkwy Ste 320 |
| City | Houston |
| State | TX |
| ZIP | 77070 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | September 2, 2020 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $8.8M |
| Medicare | $716.2K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
26 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 7,430 | $30 | $252.6K |
| 87150 | The lab analyst performs an analysis using amplified DNA or RNA probe technique on a previously isolated and identified organism to categorize the organism more specifically, such as to the taxonomic… | 3,340 | $30 | $113.4K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 2,000 | $30 | $67.8K |
| 87637 | The lab analyst performs the technical steps to detect and differentiate severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), influenza A, influenza B, and respiratory syncytial virus (RSV)… | 470 | $140 | $66.2K |
| 87631 | The lab analyst performs the technical steps to detect three to five types or subtypes of pathogens, such as adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,… | 380 | $140 | $52.6K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 480 | $70 | $35.4K |
| 87640 | The lab analyst performs the technical lab test to look for Staphylococcus aureus nucleic acid using an amplified probe technique. | 620 | $30 | $21.1K |
| 87653 | The lab analyst performs a test for Streptococcus, group B, using amplified nucleic acid probe technique. The amplified probe provides a rapid means to assess colonization by Streptococcus, group B,… | 620 | $30 | $20.9K |
| 87561 | The lab analyst performs a test for Mycobacterium avium intracellulare, MAI, using amplified nucleic acid probe technique. Mycobacteria are bacteria, sometimes called acid fast bacteria because of… | 500 | $30 | $16.8K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 480 | $30 | $11.9K |
Showing 1–10 of 26
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 26 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
26 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 87150 | 12 | 30 | 1,260 | $30 | $430.3K |
| 87637 | 7 | 70 | 40 | $140 | $404.2K |
| 87798 | 42 | 300 | 790 | $30 | $265.1K |
| 87631 | 13 | 90 | 50 | $140 | $90.1K |
| 87481 | 44 | 270 | 150 | $30 | $68.8K |
| U0003 | 17 | 60 | 100 | $70 | $64.7K |
| 87529 | 26 | 60 | 90 | $30 | $43.6K |
| 87541 | 31 | 40 | 140 | $30 | $40.8K |
| 87486 | 39 | 60 | 90 | $30 | $32.7K |
| 87581 | 40 | 70 | 80 | $30 | $32.2K |
Showing 1–10 of 26
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
29 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 27,020 | $70 | $1.8M |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 47,760 | $30 | $1.5M |
| 87150 | The lab analyst performs an analysis using amplified DNA or RNA probe technique on a previously isolated and identified organism to categorize the organism more specifically, such as to the taxonomic… | 15,330 | $60 | $874K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 12,070 | $60 | $688.2K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 32,520 | $10 | $455.2K |
| 87653 | The lab analyst performs a test for Streptococcus, group B, using amplified nucleic acid probe technique. The amplified probe provides a rapid means to assess colonization by Streptococcus, group B,… | 32,120 | $10 | $385.5K |
| 87640 | The lab analyst performs the technical lab test to look for Staphylococcus aureus nucleic acid using an amplified probe technique. | 31,920 | $10 | $383K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 15,820 | $20 | $363.8K |
| 87541 | The lab analyst performs a test for the bacteria Legionella pneumophila using amplified nucleic acid probe technique. L. pneumophila can inhabit facility water and air conditioning systems and may… | 28,060 | $10 | $336.7K |
| 87581 | The lab analyst performs a test for Mycoplasma pneumonia, a bacteria, using amplified nucleic acid probe technique. | 28,030 | $10 | $308.3K |
Showing 1–10 of 29
How this provider's Medicaid billing volume and revenue compare to other Texas providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Texas median
29 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 28 | 340 | 400 | $50 | $553.5K |
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 1 | 160 | 200 | $280 | $321.8K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 4 | 240 | 420 | $30 | $296.8K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 68 | 290 | 410 | $20 | $225K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 71 | 300 | 410 | $20 | $223.4K |
| 87631 | The lab analyst performs the technical steps to detect three to five types or subtypes of pathogens, such as adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,… | 29 | 140 | 180 | $60 | $215.9K |
| 87661 | The lab analyst performs a test for Trichomonas vaginalis using nucleic acid amplified probe technique. | 37 | 150 | 320 | $20 | $184K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 31 | 260 | 640 | $20 | $137.2K |
| 87507 | The lab analyst performs a test to detect 12 to 25 types or subtypes of a pathogen, such as Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia, that affects the gastrointestinal… | 5 | 20 | 90 | $120 | $132K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 5 | 170 | 440 | $20 | $93.6K |
Showing 1–10 of 29
Other providers in the same ZIP code as Pcltx LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Reach Unlimited, Inc. | TX | Intellectual and/or Developmental Disabilities Residential Treatment Facility | $0 | $22.4M |
| Methodist Health Centers | TX | General Acute Care Hospital | $0 | $17.3M |
| Reem Renno | TX | Specialist | $2.8M | $0 |
| Octagos Health Inc. | TX | Physiological Laboratory | $2.2M | $69.4K |
| Bdx Solutions, Inc. | TX | Physiological Laboratory | $1.1M | $543.1K |
| Kamran Sherwani | TX | Cardiovascular Disease Physician | $1.4M | $0 |
| Joel Cohen | TX | Ophthalmology Physician | $1.2M | $0 |
| Mukarram Baig | TX | Cardiovascular Disease Physician | $1M | $0 |
| Gautam Patankar | TX | Cardiovascular Disease Physician | $936.3K | $0 |
| Nidal Buheis | TX | Cardiovascular Disease Physician | $847.3K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.